TheraRadar
← Back
Data updated: Mar 29, 2026

IPSEN BIOPHARM LTD

OncologyNeurologyGastroenterology
Biotech

IPSEN BIOPHARM LTD is a biotechnology company focused on Oncology, Neurology, Gastroenterology.

2009
Since
1
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 75%
0 drugs Phase 3: 6 Phase 2: 5 Phase 1: 10
Neurology 17%
0 drugs Phase 3: 2 Phase 2: 1
Gastroenterology 8%
0 drugs Phase 2: 1 Phase 1: 3

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Bristol-Myers Squibb big-pharma
Oncology, Gastroenterology, Neurology
Takeda big-pharma
Oncology, Gastroenterology, Neurology
Pfizer big-pharma
Oncology, Gastroenterology
Amgen biotech
Oncology, Gastroenterology, Neurology
EMD SERONO INC biotech
Oncology, Neurology, Gastroenterology